The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
qiao nei zhu she ba lv fen zhi liao wan gu xing ji sui xing jing luan qiang zhi de duo zhong xin chang qi liao xiao
Pages: 58
Year: Issue:  1
Journal: World Clinical Drugs

Keyword:  巴氯芬鞘内注射试验剂量多发性硬化呼吸抑制定时记录导管并发症计量泵癫痛膜下腔;
Abstract: 本文根据多家医院的资料,进一步评价了鞘内注射巴氯芬(baclofen)治疗顽固性脊髓性痉挛强直的长期效果。方法与对象本组共有驻例脊髓性痉挛强直患者,其中59例系脊髓损伤所致,31例为多发性硬化,其它脊髓疾患2例。首先经腰穿予以试验剂量(巴氦芬50、75或100从幻,定时记录患者的呼吸率、心率、血压、位反射、痉挛评分、自主性肌肉运动以及副作用。其后对用药有效且无严重副作用者,施行可计量泵长期使用巴氯芬治疗。结果88例患者对试验剂量巴氯芬有效,而安慰剂组无1例有效。对蛛网膜下腔置入可计量泵给药3患者进行了5~41个月(平均19个月)的随访。75例长期鞘内给药的患者中,无1例死亡或出现新的或恶化的神
Related Articles
No related articles found